new asthma drug, Accolate (zafirlukast)

Zeneca is hoping to make a big splash with their new asthma drug, Accolate (zafirlukast).

It's the first drug in a new class...leukotriene receptor antagonists (LTRA). Leukotrienes have been a HUGE area for asthma research...their discovery resulted in a Nobel prize.

Leukotrienes are pro-inflammatory substances. They're released when mast cells are exposed to allergens. In the lung, leukotrienes trigger bronchoconstriction...inflammation...and edema.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote